Net sales and operating income remained roughly unchanged year on year in the Healthcare Business, indicating there was no contribution to operating income in the first quarter. An increase in SG&A expenses was the primary reason for the slackened growth in income. Five hundred million of the ¥700 million increase in SG&A expenses was accounted for by personnel expenses and R&D expenses related to the diagnostic ultrasound system business being transferred from Panasonic Healthcare Co., Ltd. R&D expenses were focused on new products with diagnostic ultrasound system and the mainstay cassette-type DR new system "Aero DR2" forecast to contribute to sales from the second quarter onward.